AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17475459 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg
Number of subjects: 18
Study 17475459 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve approach in the inguinal region using a nerve stimulator
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravenous approach
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Transsartorial approach
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration between the tibial tuberosity and the internal gastrocnemius muscle
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve approach
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration
Number of subjects: 80
Study 15620161 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravenous approach and subcutaneous infiltration
Number of subjects: 80
Study 11508654 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 20 mg intranasally
Number of subjects: 13
Study 11508654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9716275 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy for 2 weeks
Number of subjects: 13
Study 9716275 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan therapy for 4 weeks
Number of subjects: 13
Study 9716275 — intervention group
Group type: COMPARATOR
Intervention: Light therapy
Number of subjects: 13
Study 9716275 — intervention group
Group type: COMPARATOR
Intervention: Tryptophan therapy
Number of subjects: 13
Study 7989969 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]SCH 39166
Number of subjects: 12
Study 7989969 — intervention group
Group type: EXPERIMENTAL
Intervention: [11C]NNC 756
Number of subjects: 12
Study 2731087 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 34
Study 2731087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 2731087 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine and Placebo
Number of subjects: 34
Study 29858919 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 49
Study 29858919 — intervention group
Group type: COMPARATOR
Intervention: Intravenous adenosine
Number of subjects: 49
Study 28355039 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated vacuum suspension (EVS)
Number of subjects: 10
Study 28355039 — intervention group
Group type: COMPARATOR
Intervention: Nonelevated vacuum suspension (control)
Number of subjects: 10
Study 25297012 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 g per day
Number of subjects: 513
Study 25297012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 513
Study 25297012 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 513
Study 22345379 — intervention group
Group type: EXPERIMENTAL
Intervention: Having an Asthma Action Plan (AAP)
Number of subjects: 808
Study 22345379 — intervention group
Group type: COMPARATOR
Intervention: Not having an Asthma Action Plan (AAP)
Number of subjects: 808
Study 20483881 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus home telemonitoring
Number of subjects: 40
Study 20483881 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study 17651489 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral process from GPs to CMHTs
Number of subjects: 0
Study 17651489 — intervention group
Group type: EXPERIMENTAL
Intervention: CMHTs' operational practices
Number of subjects: 0
Study 15647576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (target temperature, 33 degrees C, using surface cooling techniques)
Number of subjects: 1001
Study 15647576 — intervention group
Group type: COMPARATOR
Intervention: Normothermia (target temperature, 36.5 degrees C)
Number of subjects: 1001
Study 15647576 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia
Number of subjects: 1001
Study 15647576 — intervention group
Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 1001
Study 12475511 — intervention group
Group type: EXPERIMENTAL
Intervention: Norian SRS (injectable calcium phosphate bone cement)
Number of subjects: 20
Study 12475511 — intervention group
Group type: COMPARATOR
Intervention: Functional treatment (displaced position accepted, not rereduced)
Number of subjects: 20
Study 12475511 — intervention group
Group type: EXPERIMENTAL
Intervention: Norian SRS
Number of subjects: 20
Study 12475511 — intervention group
Group type: COMPARATOR
Intervention: Functional treatment
Number of subjects: 20
Study 10424315 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg once daily
Number of subjects: 29
Study 10424315 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 29
Study 10424315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 10424315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine 60 mg
Number of subjects: 29
Study 7565974 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual in-home comprehensive geriatric assessment by gerontologic nurse practitioners
Number of subjects: 414
Study 7565974 — intervention group
Group type: COMPARATOR
Intervention: Regular medical care (Control)
Number of subjects: 414
Study 7565974 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual in-home comprehensive geriatric assessment
Number of subjects: 414
Study 1979462 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroleptics
Number of subjects: 245
Study 1979462 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 245
Study 1979462 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of neuroleptics and antidepressants
Number of subjects: 245
Study 1979462 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin coma therapy
Number of subjects: 245
Study 1979462 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic remedies
Number of subjects: 245
Study 7438754 — intervention group
Group type: EXPERIMENTAL
Intervention: Ng-T device
Number of subjects: 200
Study 7438754 — intervention group
Group type: COMPARATOR
Intervention: Cu-T 200 device
Number of subjects: 200
Study 31206586 — intervention group
Group type: EXPERIMENTAL
Intervention: New intervention for stroke
Number of subjects: 0
Study 31206586 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 29747269 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CEE + progesterone
Number of subjects: 123
Study 29747269 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose CEE + progesterone
Number of subjects: 123
Study 29747269 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose CEE + dydrogesterone
Number of subjects: 123
Study 29747269 — intervention group
Group type: COMPARATOR
Intervention: All groups (Low-dose CEE + progesterone, Standard-dose CEE + progesterone, Standard-dose CEE + dydrogesterone
Number of subjects: 123
Study 27509607 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS (transcutaneous electrical acupoint stimulation)
Number of subjects: 85
Study 27509607 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS
Number of subjects: 85
Study 27509607 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study 27509607 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group
Number of subjects: 85
Study 25515698 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed dose ASAQ (600 mg AS + 1,620 mg AQ)
Number of subjects: 54
Study 25515698 — intervention group
Group type: COMPARATOR
Intervention: Non-fixed ASAQ (600 mg AS + 1,836 mg AQ)
Number of subjects: 54
Study 22354104 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-injection US-guided AXB
Number of subjects: 120
Study 22354104 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-injection US-guided AXB
Number of subjects: 120
Study 22354104 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadruple-injection US-guided AXB
Number of subjects: 120
Study 22354104 — intervention group
Group type: COMPARATOR
Intervention: All groups (double, triple, quadruple injections)
Number of subjects: 120
Study 20034440 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free acupuncture
Number of subjects: 101
Study 20034440 — intervention group
Group type: COMPARATOR
Intervention: Conventional needle injection acupuncture
Number of subjects: 101
Study 17664116 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0
Study 17664116 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 0
Study 17664116 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study 15644019 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral Index (Aspect Medical)
Number of subjects: 21
Study 15644019 — intervention group
Group type: EXPERIMENTAL
Intervention: AAI auditory evoked potential (Danmeter)
Number of subjects: 21
Study 15644019 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy (Datex-Ohmeda)
Number of subjects: 21
Study 12370684 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic morphine epidural analgesia (TEA) - continuous infusion of 15 mg of morphine in 250 mL of normal saline at 5 mL/h.
Number of subjects: 563
Study 12370684 — intervention group
Group type: COMPARATOR
Intervention: Intravenous analgesia (IVA) - continuous infusion of 30 mg of morphine and 180 mg ketorolac in 250 mL of normal saline at 5 mL/h.
Number of subjects: 563
Study 12370684 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of TEA and IVA
Number of subjects: 563
Study 10757583 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 4 microg kg(‐1) + Propofol 2.5 mg kg(‐1)
Number of subjects: 60
Study 10757583 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 3 microg kg(‐1) + Propofol 2.5 mg kg(‐1)
Number of subjects: 60
Study 10757583 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil 30 microg kg(‐1) + Propofol 2.5 mg kg(‐1)
Number of subjects: 60
Study 9018491 — intervention group
Group type: COMPARATOR
Intervention: Diet only (DO)
Number of subjects: 33
Study 9018491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet combined with aerobic exercise (DA)
Number of subjects: 33
Study 9018491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet combined with resistance exercise (DR)
Number of subjects: 33
Study 1444652 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-TFE VA
Number of subjects: 67
Study 1444652 — intervention group
Group type: COMPARATOR
Intervention: e-PTFE
Number of subjects: 67
Study 1444652 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-TFE AVA
Number of subjects: 67
Study 1444652 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-TFE (VA and AVA)
Number of subjects: 67
Study 3866256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 100 mg
Number of subjects: 13
Study 3866256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 300 mg
Number of subjects: 13
Study 3866256 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 600 mg
Number of subjects: 13
Study 31506369 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual blood pressure measurement
Number of subjects: 294
Study 31506369 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated blood pressure measurement
Number of subjects: 294
Study 31506369 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair position blood pressure measurement
Number of subjects: 294
Study 31506369 — intervention group
Group type: COMPARATOR
Intervention: Table position blood pressure measurement
Number of subjects: 294
Study 30366647 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic scoring assessment with PIV score <8
Number of subjects: 226
Study 30366647 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic scoring assessment with PIV score ≥8
Number of subjects: 226
Study 30366647 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic scoring assessment
Number of subjects: 226
Study 27776149 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg caffeine
Number of subjects: 28
Study 27776149 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24964509 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin A levels in MS patients
Number of subjects: 68
Study 24964509 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin C levels in MS patients
Number of subjects: 68
Study 24964509 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma vitamin E levels in MS patients
Number of subjects: 68
Study 24964509 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals without MS)
Number of subjects: 68
Study 23615384 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific trunk exercises group (SEG)
Number of subjects: 64
Study 23615384 — intervention group
Group type: COMPARATOR
Intervention: Stationary cycling group (CEG)
Number of subjects: 64
Study 20092410 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal training with instruction from an attending robotic surgeon
Number of subjects: 43
Study 20092410 — intervention group
Group type: COMPARATOR
Intervention: Informal practice session with the robot
Number of subjects: 43
Study 18187374 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg oral ursodeoxycholic acid (UDCA) daily for 6 months
Number of subjects: 41
Study 18187374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 16133790 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg three times daily
Number of subjects: 46
Study 16133790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 14557560 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the VIM thalamic nucleus
Number of subjects: 6
Study 14557560 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (age- and sex-matched)
Number of subjects: 6
Study 11234738 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines and access to a fast‐track investigation service for urological conditions
Number of subjects: 66
Study 11234738 — intervention group
Group type: COMPARATOR
Intervention: Conventional tests (not accounting for clustering)
Number of subjects: 66
Study 11234738 — intervention group
Group type: COMPARATOR
Intervention: Cluster level analysis with no account for cluster size
Number of subjects: 66
Study 11234738 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted cluster level analysis
Number of subjects: 66
Study 11234738 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced statistical methods (random effects models and generalised estimating equations)
Number of subjects: 66
Study 8803645 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous flumazenil
Number of subjects: 54
Study 8803645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 1472339 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDS education intervention (lectures, role‐plays, posters, pamphlets)
Number of subjects: 641
Study 31585096 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal cerclage
Number of subjects: 111
Study 31585096 — intervention group
Group type: COMPARATOR
Intervention: High vaginal cerclage
Number of subjects: 111
Study 30807545 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurobehavioral function assessed using the Vineland Adaptive Behavior Scales, Second Edition at baseline, 3 months, and 12 months postcardiac arrest.
Number of subjects: 84
Study 30807545 — intervention group
Group type: EXPERIMENTAL
Intervention: Vineland Adaptive Behavior Scales, Second Edition scores at 3 months and 12 months.
Number of subjects: 84
Study 30807545 — intervention group
Group type: COMPARATOR
Intervention: Comparison with Therapeutic Hypothermia after Pediatric Cardiac Arrest group without precardiac arrest neurobehavioral impairment.
Number of subjects: 84
Study 27870804 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load motor control (LMC) exercises
Number of subjects: 65
Study 27870804 — intervention group
Group type: COMPARATOR
Intervention: High-load lifting (HLL) exercise (deadlift)
Number of subjects: 65
Study 25909208 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic enoxaparin (HeptronTM) for DVT therapy
Number of subjects: 114
Study 25909208 — intervention group
Group type: COMPARATOR
Intervention: Branded enoxaparin (Sanofi‐Aventis) for DVT therapy
Number of subjects: 114
Study 25909208 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic enoxaparin (HeptronTM) for DVT prophylaxis
Number of subjects: 114
Study 25909208 — intervention group
Group type: COMPARATOR
Intervention: Branded enoxaparin (Sanofi‐Aventis) for DVT prophylaxis
Number of subjects: 114
Study 22914876 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior brace treatment for over 1 year (Group A)
Number of subjects: 70
Study 22914876 — intervention group
Group type: COMPARATOR
Intervention: No prior treatment (Group B)
Number of subjects: 70
Study 21420599 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/mL diclofenac sodium
Number of subjects: 72
Study 21420599 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/mL combined diclofenac sodium and nuclear rotation
Number of subjects: 72
Study 21420599 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (Group 1)
Number of subjects: 72
Study 21420599 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (Group 2)
Number of subjects: 72
Study 21420599 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Group 3)
Number of subjects: 72
Study 19864903 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental solution (1,900 mg/kg Sn as SnCl(2), 500 mg/kg F as NaF, 500 mg/kg F as amine fluoride, pH 4.5)
Number of subjects: 20
Study 19864903 — intervention group
Group type: COMPARATOR
Intervention: NaF solution (positive control, 1,000 mg/kg F, pH 4.5)
Number of subjects: 20
Study 19864903 — intervention group
Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 20
Study 17519820 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral multi-drug chemotherapy (CCNU, cyclophosphamide, etoposide)
Number of subjects: 138
Study 17519820 — intervention group
Group type: COMPARATOR
Intervention: Classical intravenous chemotherapy (CAV: cyclophosphamide, doxorubicin, vincristine)
Number of subjects: 138
Study 15369510 — intervention group
Group type: EXPERIMENTAL
Intervention: G group (genotypic group)
Number of subjects: 134
Study 15369510 — intervention group
Group type: EXPERIMENTAL
Intervention: GP group (geno-pharmacological group)
Number of subjects: 134
Study 11443179 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg micronized estradiol‐17beta orally, twice daily for 14 days
Number of subjects: 13
Study 11443179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9488131 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed technique using one electron and three photon beams with a common isocentre for all beams aided by a multileaf collimator
Number of subjects: 30
Study 9488131 — intervention group
Group type: COMPARATOR
Intervention: Conventionally used technique using two opposed tangential photon beams
Number of subjects: 30
Study 7986469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (20 mg/day)
Number of subjects: 0
Study 7986469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7986469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril and exercise combined
Number of subjects: 0
Study 2564110 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin (10 mg/kg)
Number of subjects: 22
Study 2564110 — intervention group
Group type: COMPARATOR
Intervention: Phenobarbitone (3 mg/kg)
Number of subjects: 22
Study 31154479 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified multiple risk factor intervention
Number of subjects: 160
Study 31154479 — intervention group
Group type: COMPARATOR
Intervention: Conventional multiple risk factor intervention
Number of subjects: 160
Study 28704685 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Activity foot
Number of subjects: 21
Study 28704685 — intervention group
Group type: COMPARATOR
Intervention: Lower Activity foot
Number of subjects: 21
Study 26205747 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment (NSPT) in the form of scaling and root planing (SRP)
Number of subjects: 70
Study 26205747 — intervention group
Group type: COMPARATOR
Intervention: Control group (no periodontal therapy)
Number of subjects: 70
Study 23585306 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of ibuprofen (400 mg ibuprofen/20 mL suspension)
Number of subjects: 20
Study 21672969 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg i.v./6 weeks for 8 years
Number of subjects: 69
Study 19682233 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-hospital high-dose tirofiban
Number of subjects: 1398
Study 19682233 — intervention group
Group type: COMPARATOR
Intervention: Control (no high-dose tirofiban/placebo)
Number of subjects: 1398
Study 17237736 — intervention group
Group type: EXPERIMENTAL
Intervention: Young sex workers (16-19 years)
Number of subjects: 1000
Study 17237736 — intervention group
Group type: COMPARATOR
Intervention: Older sex workers (20 years and older)
Number of subjects: 1000
Study 14736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Hill-climbing heuristic applied to the 6-coin problem with a concrete and visualizable solution
Number of subjects: 0
Study 14736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Hill-climbing heuristic applied to a version of the problem requiring insight
Number of subjects: 0
Study 14736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Conceptual difficulty in potential insight solution
Number of subjects: 0
Study 14736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Move selection principles on the 6-coin and 10-coin (triangle) problems
Number of subjects: 0
Study 14736293 — intervention group
Group type: EXPERIMENTAL
Intervention: Postsolution receding
Number of subjects: 0
Study 11179136 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive Positive Pressure Ventilation (NPPV)
Number of subjects: 0
Study 11179136 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 0